India's Panacea Biotec to make up to 25 million doses of Sputnik V vaccine

Reuters

05 August, 2021, 10:05 pm

Last modified: 05 August, 2021, 10:08 pm

India's Panacea Biotec to make up to 25 million doses of Sputnik V vaccine

Panacea will then supply the doses to drugmaker Dr Reddy's Laboratories for distribution in India

Reuters

05 August, 2021, 10:05 pm

Last modified: 05 August, 2021, 10:08 pm

Photo: Collected

Photo: Collected

India's Panacea Biotec Ltd said on Thursday it had agreed to produce up to 25 million doses of the Sputnik V Covid-19 vaccine using the drug substance made by Russia's Generium.

Panacea will then supply the doses to drugmaker Dr. Reddy's Laboratories for distribution in India

Keep updated, follow The Business Standard's Google news channel

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Sharmin’s kitchen produces at least 50 different soy-based foods, 30 of which are supplied to upscale food shops in Dhaka. Photo: TBS

Success of soy – a village woman’s culinary buzz from Lakshmipur to Dhaka and beyond

15m | Features

Illustration: TBS

The high cost of trade chaos across a century

13h | The Big Picture

Nafis Ud Doula and Fazlee Shamim Ehsan. Sketch: TBS

How global economic turmoil is shaking up Bangladeshi trade

13h | The Big Picture

Graphics: TBS

Why holding the referendum on July Charter a 'herculean task'

13h | Panorama

Coalition of neighboring countries opposes plan to return US bases to Afghanistan.

Coalition of neighboring countries opposes plan to return US bases to Afghanistan.

12h | TBS World

Why does HRW allege abuse of the anti-terrorism law?

Why does HRW allege abuse of the anti-terrorism law?

13h | TBS Today

New Media Initiative Launched Amid Failure to 'Shut Down Fascist Media

New Media Initiative Launched Amid Failure to 'Shut Down Fascist Media

13h | TBS Today

Why are advisers and NCP leaders facing off over safe exit?

Why are advisers and NCP leaders facing off over safe exit?

14h | Podcast